27.2 C
Accra
Saturday, September 18, 2021
No menu items!

Hungarians raise €2m for sick toddler to get world’s most expensive drug

Must Read

Ashanti Gold, Inter Allies scandalous game: Spare no one, GFA!

By John Vigah On Saturday July 17, 2021, Ghana football earned rave reviews - not for its spectacular exhibition of...

UTAG threatens to resume strike if no concrete action is taken to resolve concerns

The University Teachers Association of Ghana, UTAG, has threatened to resume their strike if government remains adamant about addressing...

Local Government Minister expected to announce list of MMDCEs on Sunday September 19

Reports suggest that the Ministry of Local Government, Decentralization and Rural Development, will be announcing the final list of...

A crowdfunding campaign in Hungary raised 700 million HUF (€2 million) in just a couple days for a sick toddler in Hungary to access the world’s most expensive drug.

Zente, 19 months, has a rare muscle disorder called spinal muscular atrophy (SMA) and requires a new treatment that his parents have labelled a “cure”.

Zente’s parents started a Gofundme page on September 19 to raise money for the drug.

On Wednesday, six days after they started the campaign, Zente’s mother announced that they had raised enough money for the treatment.

The World’s Most expensive drug

SMA is a group of neuromuscular disorders that result in the loss of motor neurons and progressive muscle wasting.

Zolgensma, which was released in May this year, is only available in the United States.

In a clinical trial of the drug, 36 children with SMA received the treatment before they were two and by the end of the trial, none of them needed a permanent ventilation system to breathe.

Zente’s parents are not the only ones trying to raise money for their child’s treatment — earlier this month, another family in Belgium raised a similar amount for the same drug.

One in 10 people in Belgium donated, raising a total of €1.9 million so a 9-month-old with SMA could access Zolgensma.

Some pharmaceutical companies in the US have called the cost of the drug “immoral”, citing the fact that SMA is the leading genetic cause of death for infants.

There have been other concerns about the accuracy of the data its producer, Novartis, presented to the FDA before they approved the drug.

In response to criticism over the price of the drug Novartis has created a new “outcomes-based agreements” plan in which people only have to pay for the drug if it works.

It will also allow some insurance holders in the United States to pay for the drug over a five-year period.

Sourceeuronews

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest News

Ashanti Gold, Inter Allies scandalous game: Spare no one, GFA!

By John Vigah On Saturday July 17, 2021, Ghana football earned rave reviews - not for its spectacular exhibition of...

UTAG threatens to resume strike if no concrete action is taken to resolve concerns

The University Teachers Association of Ghana, UTAG, has threatened to resume their strike if government remains adamant about addressing their concerns. Speaking to GBC News,...

Local Government Minister expected to announce list of MMDCEs on Sunday September 19

Reports suggest that the Ministry of Local Government, Decentralization and Rural Development, will be announcing the final list of Metropolitan, Municipal and District Chief...

Eduwatch welcomes arrest of key operative behind rogue website

Think Tank, Africa Education Watch, Eduwatch has welcomed news of the arrest of the alleged dealer in WASSCE Examination leakages at Kasoa in the...

WAEC announces new dates for cancelled papers as mastermind of leakage is apprehended

By Eugenia Asumadu-Sakyi               Following the rescheduling of the Physics and Business Management papers in the ongoing West African Senior...

More Articles Like This